The Director General of the Agence de la biomédecine shall forward to the Minister for Research, within the time limit laid down in Article R. 1232-18, as necessary, any information revealing that the planned research is of such a nature as to call into question compliance with ethical principles, the need for the removal or the relevance of the research.